De Ziekte van Bechterew (Spondyloartritis)

Autor: M. Kool, D. van Zeben

Publikováno v: Bijzijn XL. 10:26-29

Spondyloartritis (SpA) is een verzamelnaam voor reumatische aandoeningen waarbij ontstekingen aanwezig zijn in het bekken en de wervelkolom. Tegenwoordig wordt er een onderscheid gemaakt tussen axiale SpA en perifere SpA. Bij axiale SpA overheersen s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::75a9aa14e443a96113c22fd117b90481
https://doi.org/10.1007/s12632-017-0100-1

Tapering conventional synthetic DMARDs in patients with early arthritis in sustained remission: 2-year follow-up of the tREACH trial

Autor: P. B. J. de Sonnaville, Andreas H. Gerards, P. H. P. de Jong, M V van Krugten, J. M. W. Hazes, Jolanda J. Luime, D. Van Zeben, B. Grillet, Ilja Tchetverikov, T.M. Kuijper, Angelique E. A. M. Weel

Publikováno v: Annals of the Rheumatic Diseases, 75(12), 2119-2123. BMJ Publishing Group

OBJECTIVES: With early and intensive treatment many patients with early RA attain remission. Aims were to investigate (1) the frequency and time to sustained remission and subsequent tapering in patients initially treated with conventional synthetic

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46d767e4be7381630d66218419ef6f3a
https://doi.org/10.1136/annrheumdis-2016-209272

Randomised comparison of initial triple DMARD therapy with methotrexate monotherapy in combination with low-dose glucocorticoid bridging therapy; 1-year data of the tREACH trial

Autor: P. B. J. de Sonnaville, J.M. Hazes, P H de Jong, H K Han, Angelique E. A. M. Weel, B van Schaeybroeck, Jolanda J. Luime, Andreas H. Gerards, M V van Krugten, D. Van Zeben, P. A. van der Lubbe, M. Huisman

Publikováno v: Annals of the Rheumatic Diseases, 73(7), 1331-1339. BMJ Publishing Group
Annals of the Rheumatic Diseases

OBJECTIVES: To compare 1-year clinical efficacy of (1) initial triple disease-modifying antirheumatic drug therapy (iTDT) with initial methotrexate (MTX) monotherapy (iMM) and (2) different glucocorticoid (GC) bridging therapies: oral versus a single

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5193473e766876041f5efe57023be5ee
https://doi.org/10.1136/annrheumdis-2013-204788

Association of Low Baseline Levels of Erythrocyte Folate With Treatment Nonresponse at Three Months in Rheumatoid Arthritis Patients Receiving Methotrexate

Autor: Saskia M F Pluijm, Jan Lindemans, M. Bulatović Ćalasan, Johanna M. W. Hazes, P. B. J. de Sonnaville, R. de Jonge, M.C. de Rotte, D. Van Zeben, Pieternella J. Barendregt, P. H. P. de Jong, P. A. van der Lubbe

Publikováno v: Arthritis & Rheumatism. 65:2803-2813

Objective To investigate whether baseline concentrations of one-carbon metabolism biomarkers are associated with treatment nonresponse and adverse events in rheumatoid arthritis (RA) patients receiving methotrexate (MTX). Methods A prospective deriva

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c08d280b33b9398cdb45472149c4cf02
https://doi.org/10.1002/art.38113

Patient-Reported Outcomes in a Randomized Trial Comparing Four Different Treatment Strategies in Recent-Onset Rheumatoid Arthritis

Autor: J. A. P. M. Ewals, Cornelia F Allaart, Yvonne P M Goekoop-Ruiterman, D. Van Zeben, Twj Huizinga, S M van der Kooij, Ben A. C. Dijkmans, Johanna M. W. Hazes, J.K. de Vries-Bouwstra, Pit J S M Kerstens, K.H. Han, Ferdinand C. Breedveld, A.J. Peeters

Publikováno v: Arthritis & Rheumatism, 61(1), 4-12. John Wiley and Sons Inc.
van der Kooij, S M, Bouwstra, J K, Goekoop-Ruiterman, Y P, Ewals, J A P M, Han, K H, Hazes, JM, Kerstens, P J S M, Peeters, AJ, van Zeben, D, Breedveld, F C, Huizinga, T W, Dijkmans, B A C & Allaart, C F 2009, ' Patient-Reported Outcomes in a Randomized Trial Comparing Four Different Treatment Strategies in Recent-Onset Rheumatoid Arthritis ', Arthritis & Rheumatism, vol. 61, no. 1, pp. 4-12 . https://doi.org/10.1002/art.24367
Arthritis & Rheumatism, 61(1), 4-12. John Wiley & Sons Ltd.

Objective To investigate the effectiveness of 4 different treatment strategies for recent-onset rheumatoid arthritis (RA) on 2-year patient-reported outcomes, including functioning and quality of life. Methods A total of 508 patients with recent-onse

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb3671d0e78e8788f56794b0358f4fe1
https://doi.org/10.1002/art.24367